Share ownership Viatris Inc.

VTRS

US92556V1061

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 18/06/2026 am IST			5-day change	1st Jan Change
15.73 ^USD	-1.93%		-0.25%	+26.35%

27/05	Argus Raises Viatris Price Target to $18 From $15	MT
19/05	Barclays Adjusts Price Target on Viatris to $22 From $17, Maintains Overweight Rating	MT

Share class: Viatris Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,25,87,29,502	1,15,94,30,518 ( 92.11 %)	9,41,76,848 ( 7.482 %)	92.11 %

Major shareholders: Viatris Inc.

Name	Stocks	%	Valuation
Davis Selected Advisers LP 6.716 %	7,82,11,191	6.716 %	1 272 M $
Vanguard Capital Management LLC 6.416 %	7,47,16,631	6.416 %	1 215 M $
BlackRock Advisors LLC 6.1 %	7,10,40,600	6.1 %	1 155 M $
T. Rowe Price International Ltd. 5.656 %	6,58,64,104	5.656 %	1 071 M $
Vanguard Portfolio Management LLC 4.629 %	5,39,11,237	4.629 %	877 M $
STATE STREET CORPORATION 4.485 %	5,22,33,699	4.485 %	849 M $
DFA Australia Ltd. 3.083 %	3,59,08,122	3.083 %	584 M $
Rubric Capital Management LP 2.877 %	3,35,00,000	2.877 %	545 M $
Geode Capital Management LLC 2.735 %	3,18,46,107	2.735 %	518 M $
Invesco Advisers, Inc. 1.886 %	2,19,68,657	1.886 %	357 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	76.35%
Others	5.26%
State Street Corp.	4.49%
SEI Investments Co.	0.38%
Individuals	0.3%
Schweizerische Nationalbank	0.2%
Manulife Financial Corp.	0.17%
Governments	0.12%
The Bank of Nova Scotia	0.08%
Fifth Third Bancorp	0.04%
ING Groep NV	0.02%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Hancock Whitney Corp.	0.02%
Sumitomo Mitsui Trust Group, Inc.	0.01%
American Financial Group, Inc.	0.01%
Ally Financial, Inc.	0.01%
The Allstate Corp.	0.01%
Unknown	12.51%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	66.94%
United Kingdom	11.24%
Australia	3.16%
Canada	1.36%
France	1.22%
Norway	0.65%
Spain	0.58%
Switzerland	0.55%
Individuals	0.3%
Germany	0.25%
Ireland	0.24%
Netherlands	0.24%
Japan	0.18%
Monaco	0.11%
Belgium	0.09%
Luxembourg	0.09%
Hong Kong	0.07%
Sweden	0.06%
Italy	0.05%
China	0.03%
Czech Republic	0.03%
Liechtenstein	0.01%
Cayman Islands	0.01%
Finland	0.01%
Mexico	0.01%

Based on 1000 largest holdings

Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.

Employees

30,000

Sector

Pharmaceuticals

More about the company